Stockholm - Delayed Quote SEK

Medivir AB (publ) (MVIR.ST)

1.7780
-0.0720
(-3.89%)
At close: 5:29:38 PM GMT+2
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,584
3,484
7,634
4,408
25,537
Operating Expense
117,655
131,555
100,386
93,016
89,938
Operating Income
-114,071
-128,071
-92,752
-88,608
-64,401
Net Non Operating Interest Income Expense
-1,909
-709
-886
-920
-950
Pretax Income
-110,517
-123,317
-89,322
-88,765
-62,579
Tax Provision
0
0
0
0
546
Net Income Common Stockholders
-110,517
-123,317
-89,322
-88,765
-63,125
Diluted NI Available to Com Stockholders
-110,517
-123,317
-89,322
-88,765
-63,125
Basic EPS
-0.97
-1.08
-1.48
-1.59
-0.98
Diluted EPS
-0.97
-1.08
-1.48
-1.59
-0.98
Basic Average Shares
114,476
114,051
60,438
55,736
64,465.3670
Diluted Average Shares
114,476
114,051
60,438
55,736
64,465.3670
Total Operating Income as Reported
-113,241
-127,341
-91,414
-87,354
-62,118
Total Expenses
117,655
131,555
100,386
93,016
89,938
Net Income from Continuing & Discontinued Operation
-110,517
-123,317
-89,322
-88,765
-63,125
Normalized Income
-115,250
-128,050
-92,299
-88,309
-64,053.9800
Interest Income
--
73
27
8
0
Interest Expense
--
782
913
928
950
Net Interest Income
-1,909
-709
-886
-920
-950
EBIT
-108,535
-122,535
-88,409
-87,837
-61,629
EBITDA
-105,807
-119,807
-85,668
-85,266
-59,034
Reconciled Depreciation
2,728
2,728
2,741
2,571
2,595
Net Income from Continuing Operation Net Minority Interest
-110,517
-123,317
-89,322
-88,765
-63,125
Total Unusual Items Excluding Goodwill
4,733
4,733
2,977
-456
1,170
Total Unusual Items
4,733
4,733
2,977
-456
1,170
Normalized EBITDA
-110,540
-124,540
-88,645
-84,810
-60,204
Tax Rate for Calcs
0
0
0
0
0.0002
Tax Effect of Unusual Items
0
0
0
0
241.0200
12/31/2021 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3500
+9.38%
 
ALZ.ST Alzinova AB (publ)
1.8060
-3.22%
 
XSPRAY.ST Xspray Pharma AB (publ)
31.50
-6.25%
 
EGTX.ST Egetis Therapeutics AB (publ)
3.4000
-1.59%
 
ELIC.ST Elicera Therapeutics AB (publ)
4.6500
-0.75%
 
CANTA.ST Cantargia AB (publ)
1.5300
-0.78%
 
BINV.ST BioInvent International AB (publ)
30.70
+12.66%
 
ACE.ST Ascelia Pharma AB (publ)
3.8150
-0.26%
 
ATORX.ST Alligator Bioscience AB (publ)
3.8600
-0.97%
 
ONCO.ST Oncopeptides AB (publ)
1.9500
-3.47%